1072 related articles for article (PubMed ID: 27852668)
1. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis.
Aldana-Aguirre JC; Pinto M; Featherstone RM; Kumar M
Arch Dis Child Fetal Neonatal Ed; 2017 Jan; 102(1):F17-F23. PubMed ID: 27852668
[TBL] [Abstract][Full Text] [Related]
2. Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis.
Rigo V; Lefebvre C; Broux I
Eur J Pediatr; 2016 Dec; 175(12):1933-1942. PubMed ID: 27678511
[TBL] [Abstract][Full Text] [Related]
3. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
[TBL] [Abstract][Full Text] [Related]
4. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.
Abdel-Latif ME; Davis PG; Wheeler KI; De Paoli AG; Dargaville PA
Cochrane Database Syst Rev; 2021 May; 5(5):CD011672. PubMed ID: 33970483
[TBL] [Abstract][Full Text] [Related]
5. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome.
Abdel-Latif ME; Walker E; Osborn DA
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD008309. PubMed ID: 38270182
[TBL] [Abstract][Full Text] [Related]
6. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
Kaniewska U; Gulczyńska E
Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
[TBL] [Abstract][Full Text] [Related]
7. Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome.
Ramos-Navarro C; Sánchez-Luna M; Zeballos-Sarrato S; González-Pacheco N
J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2704-2710. PubMed ID: 30526187
[No Abstract] [Full Text] [Related]
8. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
[TBL] [Abstract][Full Text] [Related]
9. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Harrington EW; Blennow M; Soll RF
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
[TBL] [Abstract][Full Text] [Related]
10. Five-year single center experience on surfactant treatment in preterm infants with respiratory distress syndrome: LISA vs INSURE.
Buyuktiryaki M; Alarcon-Martinez T; Simsek GK; Canpolat FE; Tayman C; Oguz SS; Kutman HGK
Early Hum Dev; 2019 Aug; 135():32-36. PubMed ID: 31229792
[TBL] [Abstract][Full Text] [Related]
11. Surfactant administration in preterm babies (28-36 weeks) with respiratory distress syndrome: LISA versus InSurE, an open-label randomized controlled trial.
Mishra A; Joshi A; Londhe A; Deshmukh L
Pediatr Pulmonol; 2023 Mar; 58(3):738-745. PubMed ID: 36416036
[TBL] [Abstract][Full Text] [Related]
12. Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial.
Kribs A; Roll C; Göpel W; Wieg C; Groneck P; Laux R; Teig N; Hoehn T; Böhm W; Welzing L; Vochem M; Hoppenz M; Bührer C; Mehler K; Stützer H; Franklin J; Stöhr A; Herting E; Roth B;
JAMA Pediatr; 2015 Aug; 169(8):723-30. PubMed ID: 26053341
[TBL] [Abstract][Full Text] [Related]
13. Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis.
Isayama T; Iwami H; McDonald S; Beyene J
JAMA; 2016 Aug; 316(6):611-24. PubMed ID: 27532916
[TBL] [Abstract][Full Text] [Related]
14. Nasal continuous positive airway pressure versus nasal intermittent positive-pressure ventilation within the minimally invasive surfactant therapy approach in preterm infants: a randomised controlled trial.
Oncel MY; Arayici S; Uras N; Alyamac-Dizdar E; Sari FN; Karahan S; Canpolat FE; Oguz SS; Dilmen U
Arch Dis Child Fetal Neonatal Ed; 2016 Jul; 101(4):F323-8. PubMed ID: 26553376
[TBL] [Abstract][Full Text] [Related]
15. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.
Xu CC; Bao YY; Zhao JX; Cheng K; Sun L; Wu JY; Wu MY; Zhu JJ
BMC Pulm Med; 2022 Dec; 22(1):462. PubMed ID: 36471386
[TBL] [Abstract][Full Text] [Related]
16. Surfactant administration methods for premature newborns: LISA vs. INSURE comparative analysis.
Mansouri M; Servatyari K; Rahmani K; Sheikhahmadi S; Hemmatpour S; Eskandarifar A; Rahimzadeh M
J Neonatal Perinatal Med; 2024; 17(2):233-239. PubMed ID: 38759030
[TBL] [Abstract][Full Text] [Related]
17. Surfactant administration without intubation in preterm infants with respiratory distress syndrome--our experiences.
Krajewski P; Chudzik A; Strzałko-Głoskowska B; Górska M; Kmiecik M; Więckowska K; Mesjasz A; Sieroszewski P
J Matern Fetal Neonatal Med; 2015 Jul; 28(10):1161-4. PubMed ID: 25065621
[TBL] [Abstract][Full Text] [Related]
18. Less Invasive Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome.
Halim A; Shirazi H; Riaz S; Gul SS; Ali W
J Coll Physicians Surg Pak; 2019 Mar; 29(3):226-330. PubMed ID: 30823947
[TBL] [Abstract][Full Text] [Related]
19. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome.
Abdel-Latif ME; Osborn DA
Cochrane Database Syst Rev; 2011 Jul; (7):CD008309. PubMed ID: 21735428
[TBL] [Abstract][Full Text] [Related]
20. Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial.
Gupta BK; Saha AK; Mukherjee S; Saha B
Eur J Pediatr; 2020 Aug; 179(8):1287-1293. PubMed ID: 32462483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
